Clinical Trial Update: Apatinib for Advanced Sarcoma: Results From Multiple Institutions' Off-label Use [NA]

View source ↗

Summary

This clinical trial update reports results from off-label use of apatinib in patients with advanced sarcoma across multiple institutions, focusing on efficacy a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Efficacy, Toxicity | NA | Status: COMPLETED